Primary acinic cell carcinoma of the breast: a case report and review of the literature.
AuthorsZhao Y, Li W, Lang R, Yang Y, Gao X, Zheng Y, Zhang C, Fu X, Fu L
JournalInt J Surg Pathol
PubMed ID23564703
Acinic cell carcinoma (ACC) of the breast is a rare tumor that is listed in the 2003 World Health Organization (WHO) classification of tumors of the breast. Pure form ACC of the breast is even rarer. To date, only 12 cases have been reported in the English-language literature. A case ... More
Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes.
AuthorsPapanikolaou V, Stefanou N, Dubos S, Papathanasiou I, Palianopoulou M, Valiakou V, Tsezou A
Journal
PubMed ID25539992
Tamoxifen is a major treatment modality for estrogen receptor positive breast cancer, but the occurrence of resistance remains a problem. Recently, obesity-related leptin has been found to interfere with tamoxifen in breast cancer MCF-7 cells. In the present study we investigated the effect of leptin on three tamoxifen-treated breast cancer ... More
An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.
AuthorsZhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y,
Journal
PubMed ID23826420
Triple negative breast cancer (TNBC) is heterogeneous and considered as an aggressive tumor. This study was to evaluate the associated classification and its correlations with prognosis and the response to chemotherapy in Chinese women. Four hundred and twenty-eight cases of invasive TNBC were involved in this study. The expression of ... More